We’ve recently updated our valuation analysis.

United Orthopedic Valuation

Is 4129 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 4129?

Other financial metrics that can be useful for relative valuation.

4129 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.3x
Enterprise Value/EBITDA7x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 4129's PE Ratio compare to its peers?

4129 PE Ratio vs Peers
The above table shows the PE ratio for 4129 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average22.8x
4155 OK Biotech
21.7xn/aNT$2.5b
6612 ICARES Medicus
28.7xn/aNT$2.9b
1786 SciVision Biotech
26.8xn/aNT$3.0b
4126 Pacific Hospital Supply
13.7x6.2%NT$4.9b
4129 United Orthopedic
24.6xn/aNT$2.4b

Price-To-Earnings vs Peers: 4129 is expensive based on its Price-To-Earnings Ratio (24.6x) compared to the peer average (22.8x).


Price to Earnings Ratio vs Industry

How does 4129's PE Ratio compare vs other companies in the TW Medical Equipment Industry?

Price-To-Earnings vs Industry: 4129 is expensive based on its Price-To-Earnings Ratio (24.6x) compared to the TW Medical Equipment industry average (19.1x)


Price to Earnings Ratio vs Fair Ratio

What is 4129's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

4129 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio24.6x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 4129's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of 4129 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 4129 (NT$30.8) is trading above our estimate of fair value (NT$11.31)

Significantly Below Fair Value: 4129 is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies